News
MarketWatch on MSN17d
23andMe’s failure shows how risky it can be to invest in a SPACThe bankruptcy underscores the great risks of investing in many of the companies that have gone public via mergers with special-purpose acquisition corporations.
Just before the 23andMe SPAC deal closed ... giving investors the impression it is a risk-free investment. Some companies do not find appropriate acquisition targets and have to redeem the ...
23andMe is going bankrupt — underscoring the great risks of investing in many of the companies that have gone public via mergers with special-purpose acquisition corporations. When companies opt ...
Me on Sunday filed for bankruptcy in the U.S. after struggling with weak demand for its ancestry testing kits and a 2023 data ...
23andMe garnered lots of attention from investors when it was first taken public via a special-purpose acquisition vehicle (SPAC ... to help drive initial investments. She will be replaced ...
Genetic analysis company 23andMe (ME) announced this week it's declaring bankruptcy and pursuing a sale, leading many customers to pursue deleting their data from the company. 23andMe was founded ...
Elicit Brewing Co. is expected to open for business in the former Barnes & Noble space in ... also made a $300 million equity investment in 23andMe. When 23andMe went public in 2021, its ...
Plus: A $3 million prize for scientists working with the Large Hadron Collider, why we’re one step closer to a holodeck and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results